| Literature DB >> 35604129 |
Jolinda de Korne-Elenbaas1,2, Sylvia M Bruisten1,3, Alje P van Dam1,2, Martin C J Maiden4, Odile B Harrison4.
Abstract
The bacterial accessory genome provides the genetic flexibility needed to facilitate environment and host adaptation. In Neisseria gonorrhoeae, known accessory elements include plasmids which can transfer and mediate antimicrobial resistance (AMR); however, chromosomal accessory genes could also play a role in AMR. Here, the gonococcal accessory genome was characterized using gene-by-gene approaches and its association with the core genome and AMR were assessed. The gonococcal accessory gene pool consisted of 247 genes, which were mainly genes located on large mobile genetic elements, phage associated genes, or genes encoding putative secretion systems. Accessory elements showed similar synteny across genomes, indicating either a predisposition for particular genomic locations or ancestral inheritance that are conserved during strain expansion. Significant associations were found between the prevalence of accessory elements and core genome multi-locus sequence types (cgMLST), consistent with a structured gonococcal population despite frequent horizontal gene transfer (HGT). Increased prevalence of putative DNA exchange regulators was significantly associated with AMR, which included a putative secretion system, methyltransferases and a toxin-antitoxin system. Although frequent HGT results in high genetic diversity in the gonococcus, we found that this is mediated by a small gene pool. In fact, a highly organized genome composition was identified with a strong association between the accessory and core genome. Increased prevalence of DNA exchange regulators in antimicrobial resistant isolates suggests that genetic material exchange plays a role in the development or maintenance of AMR. These findings enhance our understanding of gonococcal genome architecture and have important implications for gonococcal population biology. IMPORTANCE The emergence of antimicrobial resistance (AMR) against third generation cephalosporins in Neisseria gonorrhoeae is a major public health concern, as these are antibiotics of last resort for the effective treatment of gonorrhea. Although the resistance mechanisms against this class of antibiotics have not been entirely resolved, resistance against other classes of antibiotics, such as tetracyclines, is known to be mediated through plasmids, which are known gonococcal extra-chromosomal accessory elements. A complete assessment of the chromosomal accessory genome content and its role in AMR has not yet been undertaken. Here, we comprehensively characterize the gonococcal accessory genome to better understand genome architecture as well as the evolution and mechanisms of AMR in this species.Entities:
Keywords: Neisseria gonorrhoeae; accessory genome; antimicrobial resistance; core genome; pangenome; population biology
Mesh:
Substances:
Year: 2022 PMID: 35604129 PMCID: PMC9241924 DOI: 10.1128/spectrum.02654-21
Source DB: PubMed Journal: Microbiol Spectr ISSN: 2165-0497
FIG 1Workflow for the characterization of the accessory genome in N. gonorrhoeae. Genome Comparator, PIRATE, and Roary software were used on a data set of 765 isolates.
FIG 2Roary pangenome plots demonstrating relationships between numbers of genes identified and numbers of genomes used. The numbers of new (A) and conserved (B) genes saturized with less than 20 genomes. The numbers of unique (A) and total (B) genes were positively correlated with the number of genomes included in the analysis, as shown by a constant increase of identified genes when the number of genomes increased.
Functional annotations of 247 identified accessory genes in N. gonorrhoeae
| Functional category | Subcategory | No. of accessory genes | % |
|---|---|---|---|
| Mobile genetic elements | Gonococcal genomic island (GGI) | 67 | (27%) |
| Conjugative plasmid | 51 | (21%) | |
| Beta-lactamase plasmid | 8 | (3%) | |
| VirB Type IV secretion system | 30 | (12%) | |
| Putative secretion system | 7 | (3%) | |
| Methyltransferases (outside genomic islands) | 6 | (2.5%) | |
| Phage associated genes | Nf1 phage island | 6 | (2.5%) |
| Nf4 phage island | 3 | (1%) | |
| Phage island X associated | 7 | (3%) | |
| (Putative) phage associated | 18 | (7%) | |
| Genetic information processing | DNA transcription | 3 | (1%) |
| DNA replication | 1 | (0.5%) | |
| Toxin-antitoxin system | 2 | (1%) | |
| TonB- dependent receptors | 3 | (1%) | |
| Other functions | Alcohol dehydrogenase | 1 | (0.5%) |
| Putative peptidase | 1 | (0.5%) | |
| Membrane proteins | 1 | (0.5%) | |
| TspB virulence factor | 1 | (0.5%) | |
| Hypothetical genes | 31 | (12.5%) | |
| Total no. of accessory genes | 247 | 100% |
FIG 3Genomic locations of chromosomal accessory elements belonging to the gonococcal accessory genome. Locations were visualized on circular genomes of well-known reference strains. Reference strain FA1090 lacks all accessory elements and its chromosomal accessory genome is the smallest of three. Accessory elements were identified in WHO-Y and WHO-F, of which WHO-F has the largest accessory genome. From inner to outer circle: GC skew, GC content, reading frame with annotated genes.
FIG 4Minimum-spanning tree based on the N. gonorrhoeae accessory genome MLST typing scheme created in PubMLST. All 8,013 publicly available N. gonorrhoeae isolates were included in the tree. Colors represent core genome MLST groups using the 300 or fewer locus threshold (Ng_cgc_300). Clustering of colors indicated that the gonococcal accessory- and core genomes are strongly associated, confirming that the gonococcal genome is highly structured. Two separate clusters could be identified for the largest core genome MLST groups 3 and 16. The presence of these two clusters indicates divergence in both core and accessory genome content and a requirement for more stringent locus thresholds to be used to delineate these clusters. The tree was created with GrapeTree and nodes were positioned through dynamic rendering, meaning that branch lengths are not scaled. Legend shows the core genome MLST group (300 or fewer locus threshold).
Prevalence of accessory elements and significance of associations with cgMLST groups (Ng_cgc_300)
| CgMLST | No. of isolates | Gonococcal genetic island | Conjugative plasmid | Betalactamase plasmid | VirB T4SS | Nf1 phage island | Putative secretion | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Prevalence | Sign. | Prevalence | Sign. | Prevalence | Sign. | Prevalence | Sign. | Prevalence | Sign. | Prevalence | Sign. | ||
| 3 | 1452 | 99% | **** | 0% | **** | 1% | **** | 0% | * | 0% | **** | 97% | **** |
| 16 | 1433 | 20% | **** | 0% | **** | 0% | **** | 0% | * | 0% | **** | 92% | **** |
| 18 | 357 | 90% | **** | 1% | **** | 2% | **** | 0% | 15% | **** | 0% | **** | |
| 196 | 311 | 100% | **** | 4% | **** | 0% | **** | 0% | 0% | ** | 0% | **** | |
| 21 | 289 | 41% | **** | 93% | **** | 77% | **** | 0% | 0% | ** | 0% | **** | |
| 8 | 267 | 52% | **** | 0% | **** | 0% | **** | 0% | 0% | * | 95% | **** | |
| 133 | 239 | 59% | 100% | **** | 31% | **** | 0% | 0% | 93% | **** | |||
| 41 | 234 | 99% | **** | 100% | **** | 48% | **** | 0% | 0% | 0% | **** | ||
| 223 | 231 | 99% | **** | 1% | **** | 0% | **** | 0% | 0% | 0% | **** | ||
| 24 | 204 | 100% | **** | 2% | **** | 0% | **** | 0% | 0% | 0% | **** | ||
| 414 | 190 | 100% | **** | 7% | **** | 1% | **** | 0% | 0% | 0% | **** | ||
| 17 | 166 | 81% | 1% | **** | 1% | *** | 0% | 0% | 95% | **** | |||
| 219 | 159 | 9% | **** | 1% | **** | 4% | 0% | 0% | 0% | **** | |||
| 446 | 159 | 100% | **** | 100% | **** | 1% | *** | 0% | 0% | 1% | **** | ||
| 31 | 119 | 54% | 12% | * | 1% | ** | 0% | 0% | 74% | **** | |||
| 62 | 115 | 12% | **** | 100% | **** | 47% | **** | 0% | 0% | 1% | **** | ||
| 516 | 104 | 100% | **** | 0% | **** | 34% | **** | 0% | 0% | 0% | **** | ||
| 243 | 90 | 100% | **** | 76% | **** | 2% | 0% | 0% | 0% | **** | |||
| 425 | 74 | 100% | **** | 49% | * | 3% | 0% | 1% | 1% | **** | |||
| 415 | 73 | 100% | **** | 1% | **** | 0% | 0% | 100% | **** | 0% | **** | ||
| 450 | 70 | 97% | **** | 100% | **** | 1% | 1% | 0% | 0% | **** | |||
| 416 | 63 | 8% | **** | 100% | **** | 33% | *** | 0% | 0% | 0% | **** | ||
| 37 | 52 | 100% | **** | 88% | **** | 79% | **** | 0% | 0% | 2% | **** | ||
| 44 | 50 | 100% | **** | 14% | 0% | 0% | 0% | 0% | **** | ||||
| 95 | 47 | 32% | **** | 66% | **** | 4% | 0% | 0% | 98% | **** | |||
| 34 | 46 | 98% | *** | 0% | *** | 0% | 0% | 0% | 89% | **** | |||
| 498 | 42 | 100% | **** | 100% | **** | 17% | 0% | 0% | 0% | **** | |||
| 439 | 39 | 5% | **** | 90% | **** | 0% | 0% | 0% | 0% | **** | |||
| 304 | 38 | 97% | ** | 100% | **** | 3% | 5% | 89% | **** | 0% | **** | ||
| 239 | 35 | 9% | **** | 100% | **** | 83% | **** | 0% | 0% | 91% | **** | ||
| Other | 675 | ||||||||||||
| No cgMLST | 601 | ||||||||||||
| Overall | 8013 | 69% | 27% | 11% | 0.7% | 3.6% | 48% | ||||||
Adjusted p-values were calculated by multiplying the original p-value by the total number of core genome groups tested (n = 250). *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001.
Significantly less prevalent in cgMLST group compared to distribution among all isolates.
Significantly more prevalent in cgMLST group compared to distribution among all isolates.
Prevalence of accessory elements in isolates with available phenotypic data and the significance of associations
| Gonococcal genetic island | Conjugative plasmid | Betalactamase plasmid | virB T4SS | Nf1 phage island | Putative secretion system | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Susceptibility | MIC | No. of isolates | Prevalence | Sign. | Prevalence | Sign. | Prevalence | Sign. | Prevalence | Sign. | Prevalence | Sign. | Prevalence | Sign. |
| PEN S | ≤0.06 | 117 | 89% | **** | 32% |
| 0% |
| 7% | **** | 7% | 16% |
| |
| PEN I | >0.06-1.0 | 1896 | 64% | 23% | 2% | 1% | 3% | 52% | ||||||
| PEN R | >1.0 | 1074 | 74% | 33% | 33% | 0% | 3% | 53% | ||||||
| TET S | ≤0.5 | 774 | 74% | *** | 23% |
| 8% |
| 2% | *** | 4% | 37% |
| |
| TET R | >0.5 | 2143 | 66% | 28% | 14% | 1% | 3% | 57% | ||||||
| CIP S | ≤0.03 | 2098 | 65% |
| 26% | 6% |
| 2% | **** | 3% | ** | 42% |
| |
| CIP R | >0.06 | 2316 | 70% | 29% | 16% | 0% | 2% | 56% | ||||||
| CRO S | ≤0.125 | 4868 | 67% | 26% | 11% | 1% | 2% | 51% | ||||||
| CRO R | >0.125 | 22 | 91% | 14% | 0% | 0% | 0% | 77% | ||||||
| CFX S | ≤0.125 | 4,004 | 66% |
| 29% | **** | 12% | **** | 1% | 3% | **** | 47% |
| |
| CFX R | >0.125 | 490 | 85% | 2% | 1% | 0% | 0% | 93% | ||||||
| AZI S | <1.0 | 3547 | 71% | **** | 29% | **** | 13% | **** | 1% | 3% | 45% |
| ||
| AZI R | ≥1.0 | 898 | 60% | 8% | 2% | 0% | 1% | 75% | ||||||
PEN = penicillin; TET = tetracycline; CIP = ciprofloxacin; CRO = ceftriaxone; CFX = cefixime; AZI = azithromycin; S = susceptible; I = intermediate; R = resistant.
Adjusted P-values were calculated by multiplying the original P-value by the number of accessory elements tested (n = 6). *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001.
Significantly more prevalent among susceptible isolates.
Significantly more prevalent among resistant isolates.